| Ytd | -60.67% | |
| 1y | -72.11% |
| Open | 0.70 | Prev Close | 0.70 | Low | 0.70 | High | 0.70 | Mkt Cap | 32.83M |
| Vol | 844.00 | Avg Vol | 319.09K | EPS | -0.73 | P/E | -0.96 | Forward P/E | -4.15 |
| Beta | 0.78 | Short Ratio | 2.26 | Inst. Own | 40.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-04 | 50-d Avg | 0.84 | 200-d Avg | 1.55 | 1yr Est | 4.75 |
NSPR News
NSPR's positive CGUARDIANS II data show 100% acute device success, supporting a potential FDA approv
MIAMI, June 12, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Compan
MIAMI, June 11, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company
MIAMI, June 08, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company
InspireMD, Inc. (NSPR) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remark
MIAMI, May 06, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”
InspireMD, Inc. (NSPR) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus
InspireMD, Inc. (NSPR) Q1 2026 Earnings Call Transcript
- Reports total Q1 2026 revenue of $3.4 million, representing year-over-year growth of 122% - - Rece
- Strong clinical demand continues in Q1 2026 with global year-over-year unit sales growth of 53% an
MIAMI, May 01, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”
MIAMI, April 27, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Pr
NEW YORK, April 14, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating
InspireMD (NSPR) has become technically an oversold stock now, which implies exhaustion of the heavy
InspireMD, Inc. (NYSE: NSPR - Get Free Report) was down 6.7% on Tuesday. The stock traded as low as
MIAMI, March 31, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® P
InspireMD, Inc. (NSPR) Q4 2025 Earnings Call Transcript
InspireMD, Inc. (NSPR) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus
MIAMI, March 18, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Compan
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
On Tuesday, 838 companies hit new 52-week lows.
Monday saw 825 companies set new 52-week lows.
Wednesday's session saw 269 companies set new 52-week lows.
On Wednesday, 807 companies reached new 52-week lows.
When insiders purchase or sell shares, it indicates their confidence or concern around the company&#
Gainers
Gainers Synthetic Biologics, Inc. (NYSE: SYN) shares climbed 100% to close at $1.00 on Tuesday af